Covance LabCorp Expands Companion Dx Agreement With BML The agreement will initially focus on making available assays developed and validated by LabCorp's Covance business, with the first assays targeting oncology. NanoString Partners With CROs to Expand Access to Cancer Research Panel The deals with Covance, NeoGenomics Laboratories, and Navigate BioPharma Services aim to expand access to NanoString's PanCancer IO 360 Gene Expression Panel. Biocartis, Covance Sign Commercialization Agreement for Idylla Idylla molecular testing instruments will be placed at Covance sites to support customer needs for clinical trials and to validate and implement companion diagnostic applications. Mission Bio, LabCorp Collaborate on Clinical Trials, Companion Dx Development LabCorp's Covance business plans to offer single-cell services on Mission Bio's platform to pharma and to explore its use in companion diagnostics. LabCorp Q2 Revenues Rise 5 Percent, Fueled by Diagnostics Growth Total revenues reached $2.54 billion during the quarter, while LabCorp Diagnostics' revenues rose more than 8 percent to $1.80 billion. Jul 20, 2017 LabCorp's Covance Sees Place for Itself in New Drug-Dx Codevelopment Landscape Oct 26, 2015 LabCorp Reports Continued Boost From Covance Purchase as Q3 Revenues Rise 46 Percent Jul 28, 2015 LabCorp Reports 46 Percent Q2 Revenue Surge from Covance Acquisition Jul 7, 2015 Epic, LabCorp Expand Clinical Trials Pact in Asia Using Covance Capabilities Apr 27, 2015 LabCorp Reports 24 Percent Q1 Revenue Jump on Covance Acquisition Mar 25, 2015 Covance Acquisition Accelerates LabCorp's Stake in CDx Space, CEO Says Jan 23, 2015 LabCorp Prices $2.9B Offering of Senior Notes Nov 3, 2014 LabCorp to Acquire Covance for $6.1B Sep 5, 2014 In Brief This Week: EMD Serono, Massachusetts General Hospital; Rosetta Genomics; BioLegend, Covance Feb 25, 2014 LabCorp Acquires Covance's High-Complexity Genomic Laboratory Nov 18, 2013 Covance, NeoGenomics to Jointly Offer Services for Clinical Trials Nov 5, 2013 Covance and PathoQuest Partner on NGS-based Biosafety Testing Feb 27, 2013 MDx/CDx Focus: Abbott CDx for Janssen, Pharmacyclics' Lymphoma Drug; Covance, M2Gen Collaborate Premium Feb 26, 2013 Covance, M2Gen Aim to Improve Patient Recruitment for Oncology Trials Sep 19, 2012 GNS Healthcare, Covance Team on Data-Driven Personalized Medicine May 9, 2012 International Study Hopes to Identify Genetic Markers to Predict Response to Antidepressants Premium Feb 29, 2012 MedImmune Turns to NGS in Collaboration with Shanghai Chest Hospital to Study Lung Cancer Premium Oct 28, 2011 Movers & Shakers: Oct 28, 2011 Premium Aug 3, 2011 Covance to Collaborate with Broad Institute on microRNA Research Mar 29, 2011 Q&A: Covance's Tom Turi on the Rise of Sequencing in Drug Discovery and Development Premium Load More Breaking News Lunaphore Technologies, University of Bern Partner on Colorectal Cancer Study People in the News: New Appointments at Biocept, Novacyt, Centogene, Illumina, More In Brief This Week: Sophia Genetics, Twist Bioscience, Dante Labs, MGI, Codex DNA, More New Products Posted to GenomeWeb: SpeeDx, Bio-Techne, NuProbe, More DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests The Scan Interfering With Invasive Mussels The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels. Participation Analysis A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports. Right Whales' Decline A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC. Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.